Lobby organisation
Ipsen Pharma
Company · Health & pharma · HQ: France · Transparency Register entry
As of 27 October 2026, Ipsen Pharma appears in 5 declared MEP meetings (5 different MEPs), most often with European People's Party.
In their own words
“Ipsen is a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K.”
Read the rest of the statementShow less of the statement
“Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in more than 80 countries.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 5 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2022–2024. Bar length is relative to its busiest year (3 in 2022).
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 5 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 21 Nov 2024 | Oliver Schenk | Health priorities and rare diseases in the EU |
| 14 Oct 2024 | Pascal Arimont | Tackling rare diseases in Europe |
| 14 Jul 2022 | Nicolás González Casares | Medicines |
| 29 Jun 2022 | Seán Kelly | Fit for 55 Package |
| 29 Jun 2022 | Barry Andrews | Health policy and pharmaceuticals |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.